Discontinued — last reported Q4 '22
Free cash flow
Incyte Free cash flow decreased by 2.3% to $262.39M in Q4 2022 compared to the prior quarter. Year-over-year, this metric grew by 224.4%, from $80.89M to $262.39M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Detailed definition
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Peer comparison
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flowHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | |
|---|---|---|---|---|---|---|---|
| Value | $106.64M | $222.95M | $80.89M | $198.74M | $162.41M | $268.57M | $262.39M |
| QoQ Change | — | +109.1% | -63.7% | +145.7% | -18.3% | +65.4% | -2.3% |
| YoY Change | — | — | — | — | +52.3% | +20.5% | +224.4% |
Free cash flow at Other Companies
Frequently Asked Questions
- What is Incyte's free cash flow?
- Incyte (INCY) reported free cash flow of $262.39M in Q4 2022.
- How has Incyte's free cash flow changed year-over-year?
- Incyte's free cash flow increased by 224.4% year-over-year, from $80.89M to $262.39M.
- What does free cash flow mean?
- The cash remaining after a company pays for its operating expenses and capital investments.